CHASTITY FREDERICK: Open Payments
NPI 1780244970 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 28 payments from 15 companies in 2025. Trend: 2023 $175 · 2024 $579 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| AstraZeneca Pharmaceuticals LP | 5 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Daiichi Sankyo Inc. | 3 | $70 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Adaptive Biotechnologies Corporation | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $28 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Syndax Pharmaceuticals, Inc. | 1 | $22 |
Products named: KISQALI, FRUZAQLA, SCEMBLIX, KEYTRUDA, DATROWAY, LYNPARZA, clonoSEQ, ERLEADA.
Industry payments across IN — which companies pay providers there.
